- Allurion Announces Preliminary First Quarter 2024 Results
- Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Allurion Expands Virtual Care Suite to the United States
- Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
- Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
- Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
- Allurion to Participate in Cowen’s 44th Annual Health Care Conference
- Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
More ▼
Key statistics
As of last trade, Allurion Technologies Inc (ALUR:NYQ) traded at 2.09, 33.77% above the 52 week low of 1.56 set on Apr 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.07 |
---|---|
High | 2.11 |
Low | 2.01 |
Bid | 2.06 |
Offer | 2.08 |
Previous close | 2.01 |
Average volume | 71.19k |
---|---|
Shares outstanding | 47.85m |
Free float | 36.44m |
P/E (TTM) | -- |
Market cap | 96.18m USD |
EPS (TTM) | -1.91 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 17:16 BST.
More ▼